Source: Annual Congress 2001 - Gas exchange and pulmonary circulation (miscellanea)
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. N. Ekim, I. K. Oguzulgen, N. Akar, K. Demirel, M. Kitapci (Ankara, Turkey). The importance of high plasma levels of factor VIIIc in the severity of pulmonary thromboembolism. Eur Respir J 2001; 16: Suppl. 31, 1719

Member's Comments

No comment yet.

Related content which might interest you: The role of thrombophilic risk factors in the severity of pulmonary thromboembolism Source: Eur Respir J 2002; 19: 709-711 Year: 2002 Plasma high fibrinogen and low plasminogen levels predict poor prognosis in patients with inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 PP220 – Hypercoagulability in patients with stable COPD assessed by coagulation factor levels Source: ERS Lung Science Conference 2021 Year: 2021 Hypercoagulability in patients with stable COPD assessed by coagulation factor levels Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020 Elevated factor FVIII:C levels in patients with pulmonary hypertension: a marked of endothelial dysfunction? Source: Eur Respir J 2003; 22: Suppl. 45, 584s Year: 2003 Effect of serum NT-proBNP and H-FABP levels in predicting extent of acute pulmonary thromboembolism Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010 Does D-dimer levels on admission predicts venous thromboembolism in patients with COVID-19? Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021 Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion. Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Fibrinogen plasma levels and disease severity in pulmonary artery hypertension Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Serum levels of vascular endothelial growth factor in patients with active pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 341s Year: 2006 Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005 Homocysteine and serum-lipide levels in pulmonary thromboembolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Low plasma stem cell factor combined with high transforming growth factor-a identifies high-risk patients in pulmonary arterial hypertension Source: ERJ Open Res, 4 (4) 00035-2018; 10.1183/23120541.00035-2018 Year: 2018 C-reactive protein and platelet-activating factor-acetylhydrolase activity: new predictors of outcome in pulmonary hypertension Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Response of plasma von Willebrand factor to systemic endothelial injury in pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 545s Year: 2006 The role of plasma D-dimer level to detect pulmonary embolism in COPD exacerbation Source: Annual Congress 2007 - Pulmonary circulation Year: 2007 Prognostic value of D-dimer, BNP and CRP in acute pulmonary thromboembolism and relationship with echocardiography Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Type of anticoagulant therapy as a risk factor for the severity of chronic thromboembolic pulmonary hypertension Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 Elevated plasma fibrinogen associated with reduced pulmonary function Source: Eur Respir J 2001; 18: Suppl. 33, 505s Year: 2001